| Year |
Citation |
Score |
| 2016 |
Gadkar K, Yadav DB, Zuchero JY, Couch JA, Kanodia J, Kenrick MK, Atwal JK, Dennis MS, Prabhu S, Watts RJ, Joseph SB, Ramanujan S. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 26820920 DOI: 10.1016/J.Ejpb.2016.01.009 |
0.613 |
|
| 2014 |
Kanodia J, Chai D, Vollmer J, Kim J, Raue A, Finn G, Schoeberl B. Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles. Cell Communication and Signaling : Ccs. 12: 34. PMID 24885272 DOI: 10.1186/1478-811X-12-34 |
0.328 |
|
| 2014 |
Kanodia J, Finn G. Role of HSGAGs in Regulation of FGF Signaling Pathway: Insights from Mathematical Modeling Journal of Glycobiology. 4: 1-3. DOI: 10.4172/2168-958X.1000113 |
0.402 |
|
| 2012 |
Niepielko MG, Ip K, Kanodia JS, Lun DS, Yakoby N. Evolution of BMP signaling in Drosophila oogenesis: a receptor-based mechanism. Biophysical Journal. 102: 1722-30. PMID 22768927 DOI: 10.1016/J.Bpj.2012.03.026 |
0.751 |
|
| 2012 |
Kanodia JS, Liang HL, Kim Y, Lim B, Zhan M, Lu H, Rushlow CA, Shvartsman SY. Pattern formation by graded and uniform signals in the early Drosophila embryo. Biophysical Journal. 102: 427-33. PMID 22325264 DOI: 10.1016/J.Bpj.2011.12.042 |
0.746 |
|
| 2012 |
Chai DH, Kim J, Vollmer J, Radivojevic A, Kanodia J, Muda M, Schoeberl B. Abstract PR2: A systems biology approach to elucidating the consequences of complex ternary interactions of heparin, FGF ligands, and FGF receptor on downstream signaling in NSCLC cells Cancer Research. 72. DOI: 10.1158/1538-7445.Csb12-Pr2 |
0.369 |
|
| 2011 |
Kanodia JS, Kim Y, Tomer R, Khan Z, Chung K, Storey JD, Lu H, Keller PJ, Shvartsman SY. A computational statistics approach for estimating the spatial range of morphogen gradients. Development (Cambridge, England). 138: 4867-74. PMID 22007136 DOI: 10.1242/Dev.071571 |
0.747 |
|
| 2011 |
Chung K, Kim Y, Kanodia JS, Gong E, Shvartsman SY, Lu H. A microfluidic array for large-scale ordering and orientation of embryos. Nature Methods. 8: 171-6. PMID 21186361 DOI: 10.1038/Nmeth.1548 |
0.737 |
|
| 2010 |
Kavousanakis ME, Kanodia JS, Kim Y, Kevrekidis IG, Shvartsman SY. A compartmental model for the bicoid gradient. Developmental Biology. 345: 12-7. PMID 20580703 DOI: 10.1016/J.Ydbio.2010.05.491 |
0.744 |
|
| 2009 |
Kanodia JS, Rikhy R, Kim Y, Lund VK, DeLotto R, Lippincott-Schwartz J, Shvartsman SY. Dynamics of the Dorsal morphogen gradient. Proceedings of the National Academy of Sciences of the United States of America. 106: 21707-12. PMID 19996178 DOI: 10.1073/Pnas.0912395106 |
0.752 |
|
| 2009 |
Zartman JJ, Kanodia JS, Cheung LS, Shvartsman SY. Feedback control of the EGFR signaling gradient: superposition of domain-splitting events in Drosophila oogenesis. Development (Cambridge, England). 136: 2903-11. PMID 19641013 DOI: 10.1242/Dev.039545 |
0.737 |
|
| 2009 |
Zartman JJ, Kanodia JS, Yakoby N, Schafer X, Watson C, Schlichting K, Dahmann C, Shvartsman SY. Expression patterns of cadherin genes in Drosophila oogenesis. Gene Expression Patterns : Gep. 9: 31-6. PMID 18817893 DOI: 10.1016/J.Gep.2008.09.001 |
0.748 |
|
| 2008 |
Zartman J, Yakoby N, Kanodia JS, Shvartsman SY. Systems-level analysis of epithelial patterning and morphogenesis: The control of cytoskeleton and adhesion proteins by signaling pathways Aiche Annual Meeting, Conference Proceedings. |
0.716 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Tom I, Pham VC, Katschke KJ, Li W, Liang WC, Gutierrez J, Ah Young A, Figueroa I, Eshghi ST, Lee CV, Kanodia J, Snipas SJ, Salvesen GS, Lai P, Honigberg L, et al. Development of a therapeutic anti-HtrA1 antibody and the identification of DKK3 as a pharmacodynamic biomarker in geographic atrophy. Proceedings of the National Academy of Sciences of the United States of America. PMID 32345717 DOI: 10.1073/Pnas.1917608117 |
0.284 |
|
| 2007 |
Tangirala AK, Kanodia J, Shah SL. Non-negative matrix factorization for detection and diagnosis of plantwide oscillations Industrial and Engineering Chemistry Research. 46: 801-817. DOI: 10.1021/Ie0602299 |
0.249 |
|
| 2020 |
Kanodia J, Lo A, Baldwin RM, Colley K, Zhou K, Bourdet DL. Safety, Pharmacokinetics and Pharmacodynamics of TD-0714, a Novel Potent Neprilysin Inhibitor in Healthy Adult and Elderly Subjects. Clinical and Translational Science. PMID 32506827 DOI: 10.1111/Cts.12831 |
0.229 |
|
| 2020 |
Kanodia J, Lo A, Baldwin RM, Graham RA, Bourdet DL. Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain. Clinical Pharmacokinetics. PMID 32856281 DOI: 10.1007/S40262-020-00918-7 |
0.211 |
|
| 2017 |
Kanodia J, Baldwin M, Lo A, Wang D, Zhou K, Lee J, Colley K, Wang W, Bourdet D. Safety, Pharmacokinetics and Pharmacodynamics of TD-0714, a Novel Non-Renally Cleared Neprilysin Inhibitor, in Healthy Humanvolunteers: Potential for Once-Daily Dosing and Predictable Exposure in Patients Regardless of Baseline Renal Function Journal of Cardiac Failure. 23: S68. DOI: 10.1016/J.Cardfail.2017.07.192 |
0.207 |
|
| 2019 |
Gupta N, Bottino D, Simonsson USH, Musante CJ, Bueters T, Rieger TR, Macha S, Chenel M, Fancourt C, Kanodia J, Nayak S. Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and Development. Clinical Pharmacology and Therapeutics. PMID 31709519 DOI: 10.1002/Cpt.1667 |
0.183 |
|
| 2022 |
Maher J, Zhang R, Palanisamy G, Perkins K, Liu L, Brassil P, McNamara A, Lo A, Hughes A, Kanodia J, Kulyk S, Nikula K, Dengler HS, Scandurra A, Lua I, et al. Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFβ pathway inhibition. Toxicology and Applied Pharmacology. 115905. PMID 35122773 DOI: 10.1016/j.taap.2022.115905 |
0.111 |
|
| 2019 |
Bransford P, Cook J, Gupta M, Haertter S, He H, Ju R, Kanodia J, Lennernäs H, Lindley D, Polli JE, Wenning L, Wu Y. ICH M9 Guideline in development on Biopharmaceutics Classification System-based biowaivers: An Industrial Perspective from the IQ Consortium. Molecular Pharmaceutics. PMID 31846335 DOI: 10.1021/Acs.Molpharmaceut.9B01062 |
0.087 |
|
| 2023 |
Pruimboom-Brees IM, Gupta S, Chemuturi N, Booler HS, Nimz E, Ferrell Ramos M, Caruso A, Maass KF, Bantseev V, Huang Q, Choules MP, Nussbaum JC, Kanodia J, Thompson C, Durairaj C. International consortium for innovation and quality: An industry perspective on the nonclinical and early clinical development of intravitreal drugs. Clinical and Translational Science. PMID 36651217 DOI: 10.1111/cts.13480 |
0.083 |
|
| 2021 |
Sharma A, Sahasrabudhe V, Musib L, Zhang S, Younis I, Kanodia J. Time to rethink the current paradigm for assessing kidney function in drug development and beyond. Clinical Pharmacology and Therapeutics. PMID 34800044 DOI: 10.1002/cpt.2489 |
0.077 |
|
| 2023 |
Ravandi F, Bashey A, Foran JM, Stock W, Mawad R, Short NJ, Yilmaz M, Kantarjian HM, Odenike O, Patel AA, Garcha R, Ainsworth WB, Clynes R, Kanodia J, Ding Y, et al. Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia. Blood Advances. PMID 37647601 DOI: 10.1182/bloodadvances.2023010956 |
0.072 |
|
| 2021 |
Lo A, Norcliffe-Kaufmann L, Vickery R, Bourdet D, Kanodia J. Pharmacokinetics and pharmacodynamics of ampreloxetine, a novel, selective norepinephrine reuptake inhibitor, in symptomatic neurogenic orthostatic hypotension. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 33782836 DOI: 10.1007/s10286-021-00800-x |
0.065 |
|
| 2021 |
Kaufmann H, Vickery R, Wang W, Kanodia J, Shibao CA, Norcliffe-Kaufmann L, Haumann B, Biaggioni I. Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 31: 699-711. PMID 34657222 DOI: 10.1007/s10286-021-00827-0 |
0.044 |
|
| Hide low-probability matches. |